OptiNose, Inc. (OPTN)

USD 9.1

(0.33%)

Gross Profit Summary of OptiNose, Inc.

  • OptiNose, Inc.'s latest annual gross profit in 2023 was 62.35 Million USD , down -7.55% from previous year.
  • OptiNose, Inc.'s latest quarterly gross profit in 2024 Q2 was 18.42 Million USD , up 36.44% from previous quarter.
  • OptiNose, Inc. reported a annual gross profit of 67.01 Million USD in annual gross profit 2022, up 2.31% from previous year.
  • OptiNose, Inc. reported a annual gross profit of 65.5 Million USD in annual gross profit 2021, up 57.47% from previous year.
  • OptiNose, Inc. reported a quarterly gross profit of 18.42 Million USD for 2024 Q2, up 36.44% from previous quarter.
  • OptiNose, Inc. reported a quarterly gross profit of 17.59 Million USD for 2023 Q3, up 4.24% from previous quarter.

Annual Gross Profit Chart of OptiNose, Inc. (2023 - 2015)

Historical Annual Gross Profit of OptiNose, Inc. (2023 - 2015)

Year Gross Profit Gross Profit Growth
2023 62.35 Million USD -7.55%
2022 67.01 Million USD 2.31%
2021 65.5 Million USD 57.47%
2020 41.59 Million USD 41.79%
2019 29.33 Million USD 435.64%
2018 5.47 Million USD 3439.63%
2017 -164 Thousand USD -100.35%
2016 47.5 Million USD 55782.35%
2015 85 Thousand USD 0.0%

Peer Gross Profit Comparison of OptiNose, Inc.

Name Gross Profit Gross Profit Difference
Collegium Pharmaceutical, Inc. 326.16 Million USD 80.883%
Embecta Corp. 749.9 Million USD 91.685%
ANI Pharmaceuticals, Inc. 305.3 Million USD 79.576%
Dynavax Technologies Corporation 182.11 Million USD 65.762%
Esperion Therapeutics, Inc. 73.06 Million USD 14.662%
Pacira BioSciences, Inc. 490.3 Million USD 87.283%
PainReform Ltd. -15 Thousand USD 415793.333%
Aquestive Therapeutics, Inc. 29.75 Million USD -109.579%
Sunshine Biopharma, Inc. 8.33 Million USD -647.724%
SCYNEXIS, Inc. 124.51 Million USD 49.923%
China SXT Pharmaceuticals, Inc. 553.97 Thousand USD -11155.824%
Cosmos Health Inc. 4.34 Million USD -1333.567%
Journey Medical Corporation 52.52 Million USD -18.722%
Sunshine Biopharma, Inc. 8.33 Million USD -647.724%
Safety Shot Inc -74.45 Thousand USD 83844.98%
Alpha Teknova, Inc. 10.29 Million USD -505.614%
Intra-Cellular Therapies, Inc. 430.62 Million USD 85.52%
Bright Green Corporation -237.01 Thousand USD 26407.929%
Procaps Group, S.A. 239.56 Million USD 73.972%
Theratechnologies Inc. 62.12 Million USD -0.362%
Harrow Health, Inc. 90.55 Million USD 31.141%
Sonoma Pharmaceuticals, Inc. 4.74 Million USD -1214.099%
Biofrontera Inc. 16.62 Million USD -275.017%
DURECT Corporation 6.83 Million USD -812.809%
Supernus Pharmaceuticals, Inc. 523.74 Million USD 88.095%
Cronos Group Inc. 6.99 Million USD -791.931%
Ironwood Pharmaceuticals, Inc. 441.16 Million USD 85.866%
Kala Pharmaceuticals, Inc. -303 Thousand USD 20678.878%
RedHill Biopharma Ltd. 3.05 Million USD -1941.6%
Organogenesis Holdings Inc. 309.79 Million USD 79.872%
Guardion Health Sciences, Inc. 5.39 Million USD -1055.877%
Cumberland Pharmaceuticals Inc. 33.48 Million USD -86.21%
Radius Health, Inc. 307.71 Million USD 79.736%
Universe Pharmaceuticals INC 10.07 Million USD -518.721%
ProPhase Labs, Inc. 16.23 Million USD -283.977%
Phibro Animal Health Corporation 312.48 Million USD 80.046%
Procaps Group S.A. 239.56 Million USD 73.972%
Alvotech -69.42 Million USD 189.819%
TherapeuticsMD, Inc. 1.3 Million USD -4689.094%
Viatris Inc. 6.43 Billion USD 99.032%
Rockwell Medical, Inc. 8.7 Million USD -616.383%
Aytu BioPharma, Inc. 54.58 Million USD -14.231%
SIGA Technologies, Inc. 122.09 Million USD 48.929%
Tilray Brands, Inc. 223.35 Million USD 72.083%
Lifecore Biomedical, Inc. 41.85 Million USD -48.994%
Shineco, Inc. 882.16 Thousand USD -6968.268%
PetIQ, Inc. 252.74 Million USD 75.329%
Regencell Bioscience Holdings Limited -745.58 Thousand USD 8463.064%
Incannex Healthcare Limited 12 Thousand USD -519516.667%
Neurocrine Biosciences, Inc. 1.84 Billion USD 96.625%
Alimera Sciences, Inc. 61.17 Million USD -1.936%
Silver Spike Investment Corp. 8.1 Million USD -669.556%
Assertio Holdings, Inc. 125.04 Million USD 50.136%
Shuttle Pharmaceuticals Holdings, Inc. -6811.00 USD 915589.649%
Petros Pharmaceuticals, Inc. 4.19 Million USD -1387.748%
Clever Leaves Holdings Inc. 6.55 Million USD -851.098%
Cyclo Therapeutics, Inc. -2.41 Million USD 2687.114%
Avadel Pharmaceuticals plc 27.11 Million USD -129.944%
Hempacco Co., Inc. -1.21 Million USD 5228.5%
Talphera, Inc. -4.89 Million USD 1373.83%
Alvotech -69.42 Million USD 189.819%
Eagle Pharmaceuticals, Inc. 221.67 Million USD 71.871%
Lantheus Holdings, Inc. 709.54 Million USD 91.212%
Currenc Group, Inc. 17.35 Million USD -259.258%
Kamada Ltd. 52.59 Million USD -18.56%
Indivior PLC 907 Million USD 93.125%
Evoke Pharma, Inc. 4.97 Million USD -1152.402%
Flora Growth Corp. 17.73 Million USD -251.528%
Cyclo Therapeutics, Inc. -2.41 Million USD 2687.114%
Evolus, Inc. 140.52 Million USD 55.628%
HUTCHMED (China) Limited 453.55 Million USD 86.252%
Amphastar Pharmaceuticals, Inc. 343.96 Million USD 81.872%
Akanda Corp. 111.44 Thousand USD -55848.461%